Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ashwin Patkar, MD
Duke
Principal Investigator - Meera Narasimhan, MD
University of South Carolina
Principal Investigator - Nassir Ghaemi, MD MPH
Tufts Medical Center
Principal Investigator - Prakash Masand, MD
Duke
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2010
- Primary completion
- 31 Dec 2011
- Completion
- 31 Dec 2011
- Last update posted
- 24 Feb 2017
- Registered enrollment
- 49
- Registry id
- NCT01168674
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.